Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday.
from NDTV News - World-news https://ift.tt/3gRJWwc
Resent New
Discord abandons Microsoft acquisition talks: Report
Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...
